These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 31424656)
21. Long non-coding RNA cancer susceptibility candidate 2 inhibits the cell proliferation, invasion and angiogenesis of cervical cancer through the MAPK pathway. Wang XW; Zhang W Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3261-3269. PubMed ID: 31081078 [TBL] [Abstract][Full Text] [Related]
22. Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/AKT pathway. Chen R; Fang T; Liu N; Shi X; Wang J; Yu H Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2269-2280. PubMed ID: 37812238 [TBL] [Abstract][Full Text] [Related]
23. LncRNA MNX1-AS1 promotes the progression of cervical cancer through activating MAPK pathway. Liu X; Yang Q; Yan J; Zhang X; Zheng M J Cell Biochem; 2019 Mar; 120(3):4268-4277. PubMed ID: 30302806 [TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia. Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398 [TBL] [Abstract][Full Text] [Related]
25. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382. Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance. Zhang XW; Bu P; Liu L; Zhang XZ; Li J Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062 [TBL] [Abstract][Full Text] [Related]
27. Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells. Zhang R; Shi H; Ren F; Li X; Zhang M; Feng W; Jia Y Oncol Rep; 2016 Apr; 35(4):2466-72. PubMed ID: 26794135 [TBL] [Abstract][Full Text] [Related]
28. The Long Noncoding RNA TUG1 Promotes Laryngeal Cancer Proliferation and Migration. Zhang Z; Wang X; Cao S; Han X; Wang Z; Zhao X; Liu X; Li G; Pan X; Lei D Cell Physiol Biochem; 2018; 49(6):2511-2520. PubMed ID: 30261503 [TBL] [Abstract][Full Text] [Related]
29. Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma. Long J; Menggen Q; Wuren Q; Shi Q; Pi X Med Sci Monit; 2018 Mar; 24():1547-1559. PubMed ID: 29543785 [TBL] [Abstract][Full Text] [Related]
30. Knockdown of long non-coding RNA LINC00518 inhibits cervical cancer proliferation and metastasis by modulating JAK/STAT3 signaling. Wang DW; You D; Dong J; Liu TF Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):496-506. PubMed ID: 30720156 [TBL] [Abstract][Full Text] [Related]
31. Exosomal taurine up-regulated 1 promotes angiogenesis and endothelial cell proliferation in cervical cancer. Lei L; Mou Q Cancer Biol Ther; 2020 Aug; 21(8):717-725. PubMed ID: 32432954 [TBL] [Abstract][Full Text] [Related]
32. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer. Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815 [TBL] [Abstract][Full Text] [Related]
33. TUG1 promotes diabetic atherosclerosis by regulating proliferation of endothelial cells via Wnt pathway. Yan HY; Bu SZ; Zhou WB; Mai YF Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6922-6929. PubMed ID: 30402858 [TBL] [Abstract][Full Text] [Related]
34. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H; Pu J; Zhou XL; Ning YY; Bai C Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375 [TBL] [Abstract][Full Text] [Related]
35. CircAGFG1 aggravates the progression of cervical cancer by downregulating p53. Wang XH; Li J Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1704-1711. PubMed ID: 32141537 [TBL] [Abstract][Full Text] [Related]
36. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis. Xie C; Chen B; Wu B; Guo J; Cao Y Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327 [TBL] [Abstract][Full Text] [Related]
37. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling. Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088 [TBL] [Abstract][Full Text] [Related]
38. TUG1 confers cisplatin resistance in esophageal squamous cell carcinoma by epigenetically suppressing PDCD4 expression via EZH2. Xu C; Guo Y; Liu H; Chen G; Yan Y; Liu T Cell Biosci; 2018; 8():61. PubMed ID: 30519392 [TBL] [Abstract][Full Text] [Related]
39. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis. Jin X; Jiao X; Jiao J; Zhang T; Cui B Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735 [TBL] [Abstract][Full Text] [Related]
40. Screening of long non-coding RNA and TUG1 inhibits proliferation with TGF-β induction in patients with COPD. Tang W; Shen Z; Guo J; Sun S Int J Chron Obstruct Pulmon Dis; 2016; 11():2951-2964. PubMed ID: 27932875 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]